药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Trilostane
Epicaptopril
The risk or severity of hypertension can be increased when Epicaptopril is combined with Indacaterol.
Trilostane
Tiaprofenic acid
The risk or severity of hypertension can be increased when Tiaprofenic acid is combined with Indacaterol.
Trilostane
Phendimetrazine
The risk or severity of hypertension can be increased when Phendimetrazine is combined with Indacaterol.
Trilostane
Chlorphentermine
The risk or severity of hypertension can be increased when Chlorphentermine is combined with Indacaterol.
Trilostane
Tenamfetamine
The risk or severity of hypertension can be increased when Tenamfetamine is combined with Indacaterol.
Trilostane
4-Bromo-2,5-dimethoxyamphetamine
The risk or severity of hypertension can be increased when 4-Bromo-2,5-dimethoxyamphetamine is combined with Indacaterol.
Trilostane
4-Methoxyamphetamine
The risk or severity of hypertension can be increased when 4-Methoxyamphetamine is combined with Indacaterol.
Trilostane
2,5-Dimethoxy-4-ethylamphetamine
The risk or severity of hypertension can be increased when 2,5-Dimethoxy-4-ethylamphetamine is combined with Indacaterol.
Trilostane
MMDA
The risk or severity of hypertension can be increased when MMDA is combined with Indacaterol.
Trilostane
Antrafenine
The risk or severity of hypertension can be increased when Antrafenine is combined with Indacaterol.
Trilostane
Choline magnesium trisalicylate
The risk or severity of hypertension can be increased when Choline magnesium trisalicylate is combined with Indacaterol.
Trilostane
Salsalate
The risk or severity of hypertension can be increased when Salsalate is combined with Indacaterol.
Trilostane
Magnesium salicylate
The risk or severity of hypertension can be increased when Magnesium salicylate is combined with Indacaterol.
Trilostane
Mephentermine
The risk or severity of hypertension can be increased when Mephentermine is combined with Indacaterol.
Trilostane
Lumiracoxib
The risk or severity of hypertension can be increased when Lumiracoxib is combined with Indacaterol.
Trilostane
Olsalazine
The risk or severity of hypertension can be increased when Olsalazine is combined with Indacaterol.
Trilostane
Rescinnamine
The risk or severity of hypertension can be increased when Rescinnamine is combined with Indacaterol.
Trilostane
Levamlodipine
Indacaterol may decrease the antihypertensive activities of Levamlodipine.
Trilostane
Candesartan
Indacaterol may decrease the antihypertensive activities of Candesartan.
Trilostane
Naftopidil
Indacaterol may decrease the antihypertensive activities of Naftopidil.